HEART 路径实施可安全减少急性胸痛患者一年住院率
该研究为前瞻性前后对照研究,纳入 3 个美国中心 8,474 例成人急诊疑似急性冠脉综合征(ACS)患者,HEART 路径整合入电子病历作为交互式临床决策支持工具。实施后 30.7% 患者被识别为低危,其中 97.5% 在 1 年内无死亡和心梗。实施后 1 年住院率较实施前降低 7.0%(62.1% vs 69.1%;调整 OR 0.70,95%CI 0.63–0.78),1 年死亡或心梗率相似(11.6% vs 12.4%;调整 OR 1.00,95%CI 0.87–1.16)。
要点
- 急诊疑似 ACS 患者使用 HEART 路径可识别 30.7% 为低危,其中 97.5% 在 1 年内无死亡和心梗。
- HEART 路径实施后 1 年住院率 62.1% vs 实施前 69.1%,降低 7.0%(调整 OR 0.70,95%CI 0.63–0.78)。
- HEART 路径实施后 1 年死亡或心梗率 11.6% vs 实施前 12.4%,无显著差异(调整 OR 1.00,95%CI 0.87–1.16)。
- HEART 路径整合入电子病历作为交互式临床决策支持工具,用于识别低危(适合早期出院、无需负荷试验或血管造影)和非低危(适合进一步住院评估)患者。
适用人群与场景
- 年龄 21 岁及以上、因疑似急性冠脉综合征在急诊评估、无 ST 段抬高型心肌梗死的成人患者。
诊断标准与关键阈值
- HEART 路径将患者分为低危(适合早期出院,无需负荷试验或血管造影)和非低危(适合进一步住院评估)。
处置流程与药物剂量
- HEART 路径整合入电子病历作为交互式临床决策支持工具,急诊提供者前瞻性使用以识别低危或非低危患者。
研究设计与关键结果
- 研究为前瞻性前后对照研究,纳入 3 个美国中心 8,474 例成人急诊疑似 ACS 患者,实施前队列 3,713 例、实施后队列 4,761 例,纳入时间为 2013 年 11 月至 2016 年 1 月,实施前后各 12 个月。
- HEART 路径识别 30.7% 患者为低危,其中 97.5% 在 1 年内无死亡和心肌梗死。
- 1 年住院率实施后 62.1% vs 实施前 69.1%,降低 7.0%(调整 OR 0.70,95%CI 0.63–0.78)。
- 1 年死亡或心肌梗死率实施后 11.6% vs 实施前 12.4%,无显著差异(调整 OR 1.00,95%CI 0.87–1.16)。
证据类型、等级与局限
- 证据类型:前瞻性前后对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对急诊疑似 ACS 且无 ST 段抬高型心肌梗死的成人患者,实施 HEART 路径与 1 年住院率降低相关,且低危患者 1 年不良事件率低。
- HEART 路径可作为电子病历整合的临床决策支持工具,帮助识别适合早期出院无需负荷试验或血管造影的低危患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: We determine whether implementation of the HEART (History, ECG, Age, Risk Factors, Troponin) Pathway is safe and effective in emergency department (ED) patients with possible acute coronary syndrome through 1 year of follow-up.
METHODS: A preplanned analysis of 1-year follow-up data from a prospective pre-post study of 8,474 adult ED patients with possible acute coronary syndrome from 3 US sites was conducted. Patients included were aged 21 years or older, evaluated for possible acute coronary syndrome, and without ST-segment elevation myocardial infarction. Accrual occurred for 12 months before and after HEART Pathway implementation, from November 2013 to January 2016. The HEART Pathway was integrated into the electronic health record at each site as an interactive clinical decision support tool. After integration, ED providers prospectively used the HEART Pathway to identify patients with possible acute coronary syndrome as low risk (appropriate for early discharge without stress testing or angiography) or nonlow risk (appropriate for further inhospital evaluation). Safety (all-cause death and myocardial infarction) and effectiveness (hospitalization) at 1 year were determined from health records, insurance claims, and death index data.
RESULTS: Preimplementation and postimplementation cohorts included 3,713 and 4,761 patients, respectively. The HEART Pathway identified 30.7% of patients as low risk; 97.5% of them were free of death and myocardial infarction within 1 year. Hospitalization at 1 year was reduced by 7.0% in the postimplementation versus preimplementation cohort (62.1% versus 69.1%; adjusted odds ratio 0.70; 95% confidence interval 0.63 to 0.78). Rates of death or myocardial infarction at 1 year were similar (11.6% versus 12.4%; adjusted odds ratio 1.00; 95% confidence interval 0.87 to 1.16).
CONCLUSION: HEART Pathway implementation was associated with decreased hospitalizations and low adverse event rates among low-risk patients at 1-year follow-up.
参考来源
- Stopyra JP, Snavely AC, Lenoir KM, et al. HEART Pathway Implementation Safely Reduces Hospitalizations at One Year in Patients With Acute Chest Pain. Ann Emerg Med. 2020. PMID: 32736933. doi:10.1016/j.annemergmed.2020.05.035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。